NLRP2 antibody (C-Term)
Quick Overview for NLRP2 antibody (C-Term) (ABIN2787038)
Target
See all NLRP2 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- C-Term
-
Sequence
- FETLTCSSGT LRTLRLKIDD FNDELNKLLE EIEEKNPQLI IDTEKHHPWA
-
Predicted Reactivity
- Human: 100%
-
Characteristics
- This is a rabbit polyclonal antibody against NLRP2. It was validated on Western Blot.
-
Purification
- Affinity Purified
-
Immunogen
- The immunogen is a synthetic peptide directed towards the C terminal region of human NLRP2
-
-
-
-
Application Notes
- Optimal working dilutions should be determined experimentally by the investigator.
-
Comment
-
Antigen size: 1062 AA
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- Lot specific
-
Buffer
- Liquid. Purified antibody supplied in 1x PBS buffer with 0.09 % (w/v) sodium azide and 2 % sucrose.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Avoid repeated freeze-thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- For short term use, store at 2-8°C up to 1 week. For long term storage, store at -20°C in small aliquots to prevent freeze-thaw cycles.
-
-
- NLRP2 (NLR Family, Pyrin Domain Containing 2 (NLRP2))
-
Alternative Name
- NLRP2
-
Background
-
NALP proteins, such as NALP2, are characterized by an N-terminal pyrin (MIM 608107) domain (PYD) and are involved in the activation of caspase-1 (CASP1, MIM 147678) by Toll-like receptors (see TLR4, MIM 603030). They may also be involved in protein complexes that activate proinflammatory caspases (Tschopp et al., 2003 [PubMed 12563287]).
Alias Symbols: CLR19.9, FLJ20510, NALP2, NBS1, PAN1, PYPAF2
Protein Interaction Partner: SUGT1, APP, FAF1, PYCARD, IKBKG, IKBKB, CHUK, HSP90AA1, UBC, MRE11A, PYDC2, CARD8,
Protein Size: 1062 -
Molecular Weight
- 120 kDa
-
Gene ID
- 55655
-
NCBI Accession
- NM_017852, NP_060322
-
UniProt
- Q9NX02
-
Pathways
- Production of Molecular Mediator of Immune Response, Positive Regulation of Endopeptidase Activity, Inflammasome
Target
-